Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
Year: 2024
Type: article
Source: Cancer Cell
Authors: David Hsiehchen, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik El-Deiry, Emmanuel S. Antonarakis, Stephanie L. Graff, Michael J. Hall, Hossein Borghaei, Dave S.B. Hoon, Stephen V. Liu, Patrick C. Ma, Rana R. McKay, Trisha Wise-Draper, John Marshall, George W. Sledge, David Spetzler, Hao Zhu
Institutions: Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Caris Life Sciences (United States), Innsbruck Medical University, Universität Innsbruck, Brown University, University of Minnesota, Masonic Cancer Center, Lifespan, Fox Chase Cancer Center, Temple University Health System, Saint John's Health Center, Georgetown University, Penn State Cancer Institute, University of California San Diego, Moores Cancer Center, University of Cincinnati, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4404588551